232 related articles for article (PubMed ID: 32546481)
21. Alteration of the Renin-Angiotensin-Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3.
Picod A; Deniau B; Vaittinada Ayar P; Genest M; Julian N; Azibani F; Mebazaa A
Am J Respir Crit Care Med; 2021 Feb; 203(4):526-527. PubMed ID: 33152252
[No Abstract] [Full Text] [Related]
22. Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis.
Diaz JR; Ramírez CA; Nocua PA; Guzman F; Requena JM; Puerta CJ
PLoS One; 2018; 13(1):e0190618. PubMed ID: 29304092
[TBL] [Abstract][Full Text] [Related]
23. Intratubular and intracellular renin-angiotensin system in the kidney: a unifying perspective in blood pressure control.
Li XC; Zhu D; Zheng X; Zhang J; Zhuo JL
Clin Sci (Lond); 2018 Jul; 132(13):1383-1401. PubMed ID: 29986878
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidylamino-tripeptidylcarboxypeptidase NEMP3 and DPP3 (DPP III) are the same protein.
Kropotova ES; Pavlova EN; Naryzhny SN; Mosevitsky MI
Biochem Biophys Res Commun; 2022 Aug; 616():110-114. PubMed ID: 35653825
[TBL] [Abstract][Full Text] [Related]
25. Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter.
Prajapati SC; Chauhan SS
FEBS J; 2011 Sep; 278(18):3256-76. PubMed ID: 21794094
[TBL] [Abstract][Full Text] [Related]
26. Reply to Picod
Chawla LS; Bellomo R
Am J Respir Crit Care Med; 2021 Feb; 203(4):527-528. PubMed ID: 33152253
[No Abstract] [Full Text] [Related]
27. Efficient Entropy-Driven Inhibition of Dipeptidyl Peptidase III by Hydroxyethylene Transition-State Peptidomimetics.
Ivkovic J; Jha S; Lembacher-Fadum C; Puschnig J; Kumar P; Reithofer V; Gruber K; Macheroux P; Breinbauer R
Chemistry; 2021 Oct; 27(56):14108-14120. PubMed ID: 34314529
[TBL] [Abstract][Full Text] [Related]
28. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
29. Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension.
Pang X; Shimizu A; Kurita S; Zankov DP; Takeuchi K; Yasuda-Yamahara M; Kume S; Ishida T; Ogita H
Hypertension; 2016 Sep; 68(3):630-41. PubMed ID: 27456521
[TBL] [Abstract][Full Text] [Related]
30. Assignment of the dipeptidyl peptidase III gene (DPP3) to human chromosome 11 band q12-->q13.1 by in situ hybridization.
Fukasawa KM; Fukasawa K; Harada M
Cytogenet Cell Genet; 2000; 88(1-2):99-100. PubMed ID: 10773679
[No Abstract] [Full Text] [Related]
31. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11.
Medeiros MD; Turner AJ
Endocrinology; 1994 May; 134(5):2088-94. PubMed ID: 7908871
[TBL] [Abstract][Full Text] [Related]
32. Extended investigation of the substrate specificity of dipeptidyl peptidase IV from pig kidney.
Rahfeld J; Schutkowski M; Faust J; Neubert K; Barth A; Heins J
Biol Chem Hoppe Seyler; 1991 May; 372(5):313-8. PubMed ID: 1678608
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats.
Jackson EK; Zhang M; Liu W; Mi Z
J Pharmacol Exp Ther; 2007 Nov; 323(2):431-7. PubMed ID: 17726157
[TBL] [Abstract][Full Text] [Related]
34. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
Wenzl FA; Bruno F; Kraler S; Klingenberg R; Akhmedov A; Ministrini S; Santos K; Godly K; Godly J; Niederseer D; Manka R; Bergmann A; Camici GG; von Eckardstein A; Stähli B; Muller O; Roffi M; Räber L; Lüscher TF
Eur Heart J; 2023 Oct; 44(38):3859-3871. PubMed ID: 37632743
[TBL] [Abstract][Full Text] [Related]
35. Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.
Antlanger M; Bernhofer S; Kovarik JJ; Kopecky C; Kaltenecker CC; Domenig O; Poglitsch M; Säemann MD
Ann Med; 2017 Sep; 49(6):525-533. PubMed ID: 28358246
[TBL] [Abstract][Full Text] [Related]
36. Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology.
Mochel JP; Fink M; Peyrou M; Desevaux C; Deurinck M; Giraudel JM; Danhof M
Chronobiol Int; 2013 Nov; 30(9):1144-59. PubMed ID: 23931032
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum.
Heins J; Welker P; Schönlein C; Born I; Hartrodt B; Neubert K; Tsuru D; Barth A
Biochim Biophys Acta; 1988 May; 954(2):161-9. PubMed ID: 2896517
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
Shimamura M; Kawamuki K; Hazato T
J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
[TBL] [Abstract][Full Text] [Related]
39. NORMAL AND ALTERED FUNCTION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN: APPLICATIONS IN CLINICAL AND RESEARCH MEDICINE.
CONN JW; ROVNER DR; COHEN EL
Ann Intern Med; 1965 Aug; 63():266-84. PubMed ID: 14318467
[No Abstract] [Full Text] [Related]
40. Pathophysiological Implications of Dipeptidyl Peptidases.
Sato A; Ogita H
Curr Protein Pept Sci; 2017; 18(8):843-849. PubMed ID: 28356045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
